CaixaImpulse
CaixaImpulse
  • Home
  • Programmes
    • CaixaImpulse Validate
    • CaixaImpulse Consolidate
  • Projects
    • CaixaImpulse Validate
    • CaixaImpulse Consolidate
    • All
  • Community
  • News & Events
  1. Home
  2. Community

Community

‹ ›

Andrés G. Fernández

Ferrer Advanced Biotherapeutics

Mentors
  • Related projects

CM-352

CM-352

A new potent and safe antifibrinolytic agent for the prevention and treatment of hemorrhage

RNRbiotics

RNRbiotics

New strategy to combat bacterial infections

Stem cell technology

Stem cell technology

A new therapy to treat liver, lung and pancreas disease

Novel leukemia therapy

Novel leukemia therapy

Development of new therapeutic approaches for leukemia

CEMARK

CEMARK

Molecular tool to diagnose endometrial cancer

ExoLiver

ExoLiver

Liver on a Chip platform for toxicology and drug development

MBNL

MBNL

Therapeutic gene modulation of MBNL1-2 in myotonic dystrophy

SEHI

SEHI

New first-in-class treatment for Alzheimer’s disease

ITH13001

ITH13001

Preclinical development of ITH13001 as a second-generation oral treatment for multiple sclerosis

Receive information about our latest news and events

Subscribe to Newsletter
CaixaImpulse

The first comprehensive programme in Spain for the development of bio-health projects

If you need to contact us, please send an email to:

info@caixaimpulse.com
  • Programmes
    • CaixaImpulse Validate
    • CaixaImpulse Consolidate
  • Projects
    • CaixaImpulse Validate
    • CaixaImpulse Consolidate
    • All
  • Community
  • News & Events
  • Follow #Caixaimpulse

This activity takes place in the framework of EIT-Health with the collaboration of TuDelft and TECNALIA Ventures

  • How to navigate this site
  • Contact us
  • Accessibility
  • Cookies
  • Legal notice and Privacy
  • © Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona, ”la Caixa”. All rights reserved.

This activiy has received funding from the European Institute of Innovation and Technology (EIT). This body of the European Union receives support from the European Union's Horizon 2020 research and innovation programme.